Assessing Subject Privacy and Data Confidentiality in an Emerging Region for Clinical Trials: United Arab Emirates

Satish Chandrasekhar Nair, Halah Ibrahim

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Pharmaceutical sponsored clinical trials, formerly conducted predominantly in the United States and Europe, have expanded to emerging regions, including the Middle East. Our study explores factors influencing clinical trial privacy and confidentiality in the United Arab Emirates. Factors including concept familiarity, informed consent compliance, data access, and preservation, were analyzed to assess current practices in the Arab world. As the UAE is an emerging region for clinical trials, there is a growing need for regulations related to data confidentiality and subject privacy. Informational and decisional privacy should be viewed within the realms of Arab culture and religious background.

Original languageBritish English
Pages (from-to)205-220
Number of pages16
JournalAccountability in Research
Volume22
Issue number4
DOIs
StatePublished - 4 Jul 2015

Keywords

  • culture
  • privacy and confidentiality
  • regulatory

Fingerprint

Dive into the research topics of 'Assessing Subject Privacy and Data Confidentiality in an Emerging Region for Clinical Trials: United Arab Emirates'. Together they form a unique fingerprint.

Cite this